RJKBIO Trademark

Trademark Overview

On Tuesday, July 2, 2024, a trademark application was filed for RJKBIO with the United States Patent and Trademark Office. The USPTO has given the RJKBIO trademark a serial number of 98630207. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 18, 2025. This trademark is owned by RJK Biopharma Inc.. The RJKBIO trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Biological tissue cultures for medical purposes; Collyrium; Medicinal drinks; Amino acids for medical purposes; Diagnostic preparations for medical purposes; Enzymes for medical purposes; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Enzyme preparations for medical purposes; Dietetic foods adapted for medical purposes; All the above-mentioned goods relating to neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration
rjkbio

General Information

Serial Number98630207
Word MarkRJKBIO
Filing DateTuesday, July 2, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2025

Trademark Statements

Goods and ServicesBiological preparations for the treatment of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Biological tissue cultures for medical purposes; Collyrium; Medicinal drinks; Amino acids for medical purposes; Diagnostic preparations for medical purposes; Enzymes for medical purposes; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Enzyme preparations for medical purposes; Dietetic foods adapted for medical purposes; All the above-mentioned goods relating to neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRJK Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSHANGHAI 201315
CN
Party NameRJK Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSHANGHAI 201315
CN

Trademark Events

Event DateEvent Description
Tuesday, July 2, 2024NEW APPLICATION ENTERED
Tuesday, July 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 27, 2024ASSIGNED TO EXAMINER
Sunday, December 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

rjkbio purposes disease medical preparations cataract related macular alzheimer neurodegenerative degeneration